Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Produced in collaboration with the Global HIV Vaccine Enterprise at the International AIDS Society (IAS), this 4-episode podcast series features conversations between world-renowned guests in HIV vaccine development, HIV advocacy, and HIV policy to bust myths and address arguments for why an HIV vaccine is still needed and how we can continue working toward this ultimate game-changer for durable control of the HIV epidemic. In this episode, Dr. Swati Gupta and Mr. Marc Dixneuf discuss how to broaden global advocacy and increase investment for an HIV vaccine.
Presenters:
Swati Gupta, DrPH, MPH
Vice President and Head of Emerging Infectious Diseases and Scientific Strategy
International AIDS Vaccine Initiative
New York, New York
Marc Dixneuf, PhD
Director General
AIDES
Pantin, France
Special Commentator:
Jonathan Weber, MB, BChir, PhD, FRCP, FRCPath, FMed Sci
Dean of the Faculty of Medicine
Imperial College
London, United Kingdom
Link to the HIV unmuted series from IAS:
https://bit.ly/3f5qC0d
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
Expert HIV faculty analyze new data from CROI 2022, from Clinical Care Options (CCO)
Clinical Care Options (CCO) presents expert faculty discussing the barriers and solutions to expanding PrEP uptake, from a nursing perspective
Clinical Care Options (CCO) downloadable slides from Dr Darrell Tan, providing an overview of available long-acting ART for HIV treatment and prevention
Clinical Care Options (CCO) downloadable slides from Cristina Mussini, MD, providing practical insights into implementing long-acting ART into HIV care
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.